About Us

Canon Medical Diagnostics Corporation (the former Minaris Medical Co., Ltd.) was established in 1981 as a manufacturer specializing in in vitro diagnostics (IVD), upon carve-out from Kyowa Hakko Kogyo K.K. (the current Kyowa Kirin Co., Ltd.). Ever since our establishment, we have grown through our provision of new functions and value demanded by the times in the fields of biochemistry and immunology, based on the world's first lipid measurement technology applying an enzyme method. We are deeply grateful to the customers who have preferred our products, the transaction partners that have supported us, and all other parties concerned with our activities over the years.

In July 2023, we joined Canon Medical Systems Group, marking a bold new step forward in our journey.

We shall apply our research and development capabilities backed by innovative technology to keep providing distinctive, state-of-the art IVD products, and take up challenges with a view to further advancement and growth.

Japan and other developed countries making the transition to aged societies are facing the issue of higher medical costs and diversifying medical needs. In this situation, the role played by clinical examinations in areas such as evidenced-based treatment of disease and prevention of disease in a pre-symptomatic state for the extension of healthy life expectancy is going to assume even more importance. We aspire to be a company that contributes to human health and fulfillment, and is preferred by medical professionals. To this end, we shall fuse our own technologies with the unique technologies of Canon Group in efforts to propose products and services supporting prevention, diagnosis, and treatment while instilling clinical examinations with additional value, toward the achievement of futuristic, personalized medicine. We are also determined to acquire a solid position as a leading "niche player" on a global level in the life science field.

Our business is directly linked to human life and health. Besides assurance of quality, establishment of a system for safety management, and rigorous compliance with all pertinent laws and regulations, we are committed to the possession of a high sense of ethics by each and every one of our employees, and shall continue to earnestly address our responsibilities to our customers and society as a whole while practicing management with a high degree of transparency.

President and Managing Director
Naoki Kanenari

We are committed to addressing people's health with sincerity, delivering new value to clinical diagnostics, and continuing to grow while fulfilling our social responsibilities.

By strengthening and expanding our unique areas of expertise, we aim to establish our position as a global company and develop diagnostic technologies and products that support "prevention, diagnosis, and treatment" to realize personalized healthcare.